Skip to main content
. Author manuscript; available in PMC: 2009 Jul 14.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2008;20(4):419–430. doi: 10.1176/appi.neuropsych.20.4.419

TABLE 1.

Subject Sample Demographics and Clinical Characteristics

Characteristic Patient Group (n=26) Comparison Group (n=17)
Age in years (SD) 30.0 (9.8) 28.0 (11.6)
Number (%) of females 7 (27) 7 (41)
Number (%) of right-handed subjects 20 (77) 16 (94)
Number (%) of Caucasian subjects 19 (73) 15 (88)
Education in years (SD) 12.6 (2.2) 15.9 (3.3)
Age at illness onset in years (SD) 22.6 (5.7)
Illness duration in months (SD) 90 (96)
Number of patients taking antipsychotic medication (atypical) 24 (24)
Antipsychotic daily dosage of chlorpromazine (SD) 477 (314)
Past history of alcohol abuse | dependence 3 | 4 unknown

Data values represent group means except where indicated otherwise. Dashes indicate not applicable.

Mean years of education, based on incomplete information (four missing from comparison group; three from patient group).